CMP-001 and Pre-operative Stereotactic Body Radiation Therapy (SBRT) in Early Stage Triple Negative Breast Cancer (TNBC)
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer
Interventions: RADIATION: stereotactic body radiotherapy|DRUG: CMP-001
Sponsor: Centre Hospitalier Universitaire Vaudois